Total Payments
$22,968
2024 Payments
$2,846
Companies
46
Transactions
1,156
Medicare Patients
3,676
Medicare Billing
$398,844
Payment Breakdown by Category
Food & Beverage$22,898 (99.7%)
Education$35.31 (0.2%)
Other$35.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,898 | 1,150 | 99.7% |
| Education | $35.31 | 5 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $5,845 | 267 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,819 | 128 | $0 (2024) |
| Novo Nordisk Inc | $2,114 | 136 | $0 (2024) |
| Lilly USA, LLC | $1,687 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,546 | 75 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,078 | 57 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,008 | 44 | $0 (2024) |
| Amarin Pharma Inc. | $872.31 | 48 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $751.82 | 37 | $0 (2024) |
| PFIZER INC. | $721.00 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,846 | 127 | AstraZeneca Pharmaceuticals LP ($582.68) |
| 2023 | $2,743 | 132 | Novo Nordisk Inc ($518.69) |
| 2022 | $3,020 | 148 | Janssen Pharmaceuticals, Inc ($643.21) |
| 2021 | $3,500 | 184 | Janssen Pharmaceuticals, Inc ($976.05) |
| 2020 | $3,149 | 167 | Janssen Pharmaceuticals, Inc ($860.69) |
| 2019 | $3,331 | 130 | Janssen Pharmaceuticals, Inc ($1,804) |
| 2018 | $2,339 | 144 | Janssen Pharmaceuticals, Inc ($608.51) |
| 2017 | $2,041 | 124 | Janssen Pharmaceuticals, Inc ($376.54) |
All Payment Transactions
1,156 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $28.03 | General |
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $34.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: PAIN | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: Diabetes | ||||||
| 10/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 915 | 1,211 | $195,926 | $104,704 |
| 2022 | 11 | 1,010 | 1,348 | $217,207 | $115,528 |
| 2021 | 11 | 907 | 1,305 | $198,593 | $101,125 |
| 2020 | 12 | 844 | 1,215 | $181,134 | $77,488 |
Total Patients
3,676
Total Services
5,079
Medicare Billing
$398,844
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 438 | $83,220 | $41,107 | 49.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 163 | 163 | $43,195 | $25,293 | 58.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 193 | $29,110 | $12,194 | 41.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 108 | 108 | $10,800 | $8,187 | 75.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 44 | $11,176 | $7,442 | 66.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 164 | 164 | $7,380 | $6,038 | 81.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,225 | $2,550 | 60.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 55 | 55 | $2,750 | $1,125 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,168 | $470.40 | 14.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 22 | $902.00 | $295.89 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 400 | $76,000 | $39,873 | 52.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 163 | 163 | $43,195 | $25,555 | 59.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 164 | 295 | $44,250 | $17,655 | 39.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 118 | 118 | $11,800 | $8,150 | 69.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 52 | $13,208 | $7,895 | 59.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 171 | 172 | $7,740 | $6,279 | 81.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 19 | $8,740 | $4,439 | 50.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 17 | 17 | $5,950 | $3,358 | 56.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 54 | 54 | $2,700 | $1,083 | 40.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 14 | $1,820 | $716.36 | 39.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 38 | 44 | $1,804 | $523.65 | 29.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 223 | 466 | $88,540 | $45,441 | 51.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 146 | 293 | $43,950 | $19,801 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 64 | 64 | $16,720 | $10,023 | 59.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 41 | 44 | $11,176 | $7,194 | 64.4% |
About Dr. Alice Yan, M.D
Dr. Alice Yan, M.D is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245265362.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alice Yan, M.D has received a total of $22,968 in payments from pharmaceutical and medical device companies, with $2,846 received in 2024. These payments were reported across 1,156 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($22,898).
As a Medicare-enrolled provider, Yan has provided services to 3,676 Medicare beneficiaries, totaling 5,079 services with total Medicare billing of $398,844. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Daly City, CA
- Active Since 07/11/2006
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1245265362
Products in Payments
- XARELTO (Drug) $4,385
- INVOKANA (Drug) $1,410
- FARXIGA (Drug) $1,338
- JARDIANCE (Drug) $1,301
- Ozempic (Drug) $974.83
- ELIQUIS (Drug) $928.41
- Vascepa (Drug) $872.31
- TRELEGY ELLIPTA (Drug) $733.34
- JANUVIA (Drug) $707.84
- Kerendia (Drug) $700.66
- Rybelsus (Drug) $565.18
- TRULICITY (Drug) $544.06
- BREZTRI (Drug) $497.82
- MOUNJARO (Drug) $488.78
- Edarbi (Drug) $401.18
- STIOLTO RESPIMAT (Drug) $353.25
- NURTEC ODT (Drug) $341.68
- SOLIQUA 100/33 (Biological) $280.66
- EMGALITY (Drug) $280.61
- BEVESPI AEROSPHERE (Drug) $278.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Internal Medicine $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Internal Medicine $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Internal Medicine $39,667
Damon Lee, Md, MD
Internal Medicine — Payments: $20,608
Internal Medicine $20,608
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620
Internal Medicine $18,620
Dr. Yin-Yin Myint, M.d, M.D
Internal Medicine — Payments: $13,665
Internal Medicine $13,665